Moderna | MRNA - Loan Capital



Moderna reported $32M in Loan Capital for its fiscal quarter ending in June of 2025.


Loan Capital Change Date
Acadia Pharmaceuticals USD 0 0 Mar/2025
Adcock Ingram Holdings ZAR 220.08M 18M Dec/2024
Agios Pharmaceuticals USD 0 0 Mar/2025
Alnylam Pharmaceuticals USD 1.03B 956K Jun/2025
Amgen USD 53.76B 253M Jun/2025
Arrowhead Research USD 200.33M 8.59M Jun/2025
Biogen USD 6.28B 1.74B Jun/2025
BioMarin Pharmaceutical USD 596.16M 512K Jun/2025
Celltrion KRW 114.04B 8.35B Mar/2025
Cspc Pharmaceutical CNY 56.14M 10.18M Dec/2024
Dianthus Therapeutics USD 0 0 Dec/2024
Divis Laboratories Ltd 20M 0 Mar/2025
Gilead Sciences USD 22.14B 6M Jun/2025
GlaxoSmithKline GBP 15.3B 1.17B Jun/2025
Incyte USD 31.76M 883K Jun/2025
Ionis Pharmaceuticals USD 625.49M 625.22M Jun/2025
Kangmei Pharma CNY 84.24M 3.67M Jun/2025
Knight Therapeutics CAD 36.51M 2.04M Sep/2024
Laboratorios Farma EUR 101.36M 20.86M Jun/2025
Malin Corporation EUR 0 0 Dec/2024
Moderna USD 32M 3M Jun/2025
Organigram Holdings CAD 52.8M 9.51M Jun/2025
Pharma Mar EUR 37.57M 2.66M Jun/2025
Qiagen NV USD 884.85M 467.8M Jun/2025
Regeneron Pharmaceuticals USD 1.99B 719.7M Jun/2025
Sarepta Therapeutics USD 1.14B 1.17M Jun/2025
Sartorius EUR 4.09B 112.3M Jun/2025
Sino Biopharmaceutical CNY 2.08B 915.48M Dec/2024
Tilray USD 316.63M 15.02M Nov/2024
Ultragenyx Pharmaceutical USD 782.75M 782.75M Jun/2025
United Therapeutics USD 0 0 Mar/2025
Vertex Pharmaceuticals USD 112.8M 1.2M Dec/2024
Zz Pientze Pharmaceu 196.31M 8.23M Jun/2025